
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10776584
[patent_doc_number] => 20160122740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 14/981981
[patent_app_country] => US
[patent_app_date] => 2015-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12324
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14981981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/981981 | FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND METHOD FOR ITS PRODUCTION | Dec 28, 2015 | Abandoned |
Array
(
[id] => 16414510
[patent_doc_number] => 10822386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Insulin analogues with enhanced stability and reduced mitogenicity
[patent_app_type] => utility
[patent_app_number] => 15/539450
[patent_app_country] => US
[patent_app_date] => 2015-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9623
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539450
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539450 | Insulin analogues with enhanced stability and reduced mitogenicity | Dec 23, 2015 | Issued |
Array
(
[id] => 11798088
[patent_doc_number] => 09538779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Tube feed formulations and methods for using same'
[patent_app_type] => utility
[patent_app_number] => 14/966800
[patent_app_country] => US
[patent_app_date] => 2015-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18674
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966800
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/966800 | Tube feed formulations and methods for using same | Dec 10, 2015 | Issued |
Array
(
[id] => 11025109
[patent_doc_number] => 20160222064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/960206
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 22026
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14960206
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/960206 | HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE | Dec 3, 2015 | Abandoned |
Array
(
[id] => 15054845
[patent_doc_number] => 10457711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => Dermatophagoides farinae protein
[patent_app_type] => utility
[patent_app_number] => 15/532256
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7006
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15532256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/532256 | Dermatophagoides farinae protein | Nov 30, 2015 | Issued |
Array
(
[id] => 13237001
[patent_doc_number] => 10131691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Compositions and methods for specific regulation of pyruvate dehydrogenase kinase
[patent_app_type] => utility
[patent_app_number] => 14/943735
[patent_app_country] => US
[patent_app_date] => 2015-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 31
[patent_no_of_words] => 12237
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14943735
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/943735 | Compositions and methods for specific regulation of pyruvate dehydrogenase kinase | Nov 16, 2015 | Issued |
Array
(
[id] => 10767920
[patent_doc_number] => 20160114075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'PHOTOACTIVATED CROSSLINKING OF A PROTEIN OR PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 14/941814
[patent_app_country] => US
[patent_app_date] => 2015-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16915
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14941814
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/941814 | Photoactivated crosslinking of a protein or peptide | Nov 15, 2015 | Issued |
Array
(
[id] => 12137053
[patent_doc_number] => 20180015136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'THERAPEUTIC HOMODIMER AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/527904
[patent_app_country] => US
[patent_app_date] => 2015-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14439
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527904
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527904 | THERAPEUTIC HOMODIMER AND USES THEREOF | Nov 15, 2015 | Abandoned |
Array
(
[id] => 12000249
[patent_doc_number] => 20170304405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'TREATMENT OF HORMONAL DISORDERS OF GROWTH'
[patent_app_type] => utility
[patent_app_number] => 15/525928
[patent_app_country] => US
[patent_app_date] => 2015-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27294
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15525928
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/525928 | Treatment of hormonal disorders of growth | Nov 11, 2015 | Issued |
Array
(
[id] => 12657004
[patent_doc_number] => 20180110834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS AND PREDICTION OF CLINICAL SENSITIVITY TO TREATMENT OF BILE ACID-RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/524896
[patent_app_country] => US
[patent_app_date] => 2015-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524896
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/524896 | Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders | Nov 5, 2015 | Issued |
Array
(
[id] => 10774625
[patent_doc_number] => 20160120781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'SKINCARE FORMULATIONS AND REGIMENS'
[patent_app_type] => utility
[patent_app_number] => 14/931744
[patent_app_country] => US
[patent_app_date] => 2015-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8381
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14931744
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/931744 | Skincare formulations and regimens | Nov 2, 2015 | Issued |
Array
(
[id] => 10770302
[patent_doc_number] => 20160116457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'TRANSMEMBRANE PROTEINS AS BIOSENSORS'
[patent_app_type] => utility
[patent_app_number] => 14/930395
[patent_app_country] => US
[patent_app_date] => 2015-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 19792
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930395
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/930395 | TRANSMEMBRANE PROTEINS AS BIOSENSORS | Nov 1, 2015 | Abandoned |
Array
(
[id] => 14031643
[patent_doc_number] => 10227561
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Methods and compositions for targeting progenitor cell lines
[patent_app_type] => utility
[patent_app_number] => 14/930505
[patent_app_country] => US
[patent_app_date] => 2015-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 24289
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14930505
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/930505 | Methods and compositions for targeting progenitor cell lines | Nov 1, 2015 | Issued |
Array
(
[id] => 10761978
[patent_doc_number] => 20160108132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'Antitumor Peptide Derived From A Complementarity Determining Region of a Humanized Monoclonal Antibody to NAP12B Transporter'
[patent_app_type] => utility
[patent_app_number] => 14/924003
[patent_app_country] => US
[patent_app_date] => 2015-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 12480
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14924003
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/924003 | Antitumor peptide derived from a complementarity determining region of a humanized monoclonal antibody to NAP12B transporter | Oct 26, 2015 | Issued |
Array
(
[id] => 13479661
[patent_doc_number] => 20180291373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => USE OF THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/522600
[patent_app_country] => US
[patent_app_date] => 2015-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522600
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522600 | USE OF THERAPEUTIC AGENTS | Oct 25, 2015 | Abandoned |
Array
(
[id] => 10820490
[patent_doc_number] => 20160166654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'COLLAGEN-TARGETED NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 14/884646
[patent_app_country] => US
[patent_app_date] => 2015-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11341
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14884646
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/884646 | COLLAGEN-TARGETED NANOPARTICLES | Oct 14, 2015 | Abandoned |
Array
(
[id] => 11555228
[patent_doc_number] => 20170101474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'SYNTHETIC ANTIBODY MIMIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/882436
[patent_app_country] => US
[patent_app_date] => 2015-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 18795
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882436
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/882436 | Synthetic antibody mimic peptides | Oct 12, 2015 | Issued |
Array
(
[id] => 16892075
[patent_doc_number] => 11033602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Inhalation device
[patent_app_type] => utility
[patent_app_number] => 15/516286
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8743
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516286
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/516286 | Inhalation device | Sep 30, 2015 | Issued |
Array
(
[id] => 10693796
[patent_doc_number] => 20160039943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'METHOD OF INCREASING PLASMIN ACTIVITY THROUGH ANTIPLASMIN CONVERSION'
[patent_app_type] => utility
[patent_app_number] => 14/872776
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10539
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872776
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872776 | Method of increasing plasmin activity through antiplasmin conversion | Sep 30, 2015 | Issued |
Array
(
[id] => 11956085
[patent_doc_number] => 20170260236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'COMPOSITIONS FOR EXPANDING REGULATORY T CELLS (TREG), AND TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES AND CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/510667
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 21982
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510667
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510667 | Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions | Sep 28, 2015 | Issued |